
Herbal Medicines Used in Treatment of Nonalcoholic Fatty Liver Disease: A Mini-Review
Masoodi M, Rezadoost A, Panahian M, Vojdanian M. Effects of Silymarin on Reducing Liver Aminotransferases in Patients with Nonalcoholic Fatty Liver Diseases. Govaresh. 2013;18(3):181-5.
Iloon Kashkooli R, Najafi SS, Sharif F, Hamedi A, Hoseini Asl MK, Najafi Kalyani M, et al. The effect of berberis vulgaris extract on transaminase activities in non-alcoholic Fatty liver disease. Hepat Mon. 2015;15(2):e25067.
Alavian SM, Mohammad-Alizadeh AH, Esna-Ashari F, Ardalan G, Hajarizadeh B. Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures. Liver Int. 2009;29(2):159-63.
Lankarani KB, Ghaffarpasand F, Mahmoodi M, Lotfi M, Zamiri N, Heydari ST, et al. Non Alcoholic Fatty Liver Disease in Southern Iran: A Population Based Study. Hepat Mon. 2013;13(5):e9248.
Gu C-l, Zhang Y-k, Fu Y-x, Yang S-f, Li X-q. Effect of Tiaozhi Yanggan Decoction (调脂养肝汤) in treating patients with non-alcoholic fatty liver. Chin J Integr Med. 2007;13:275-9.
Assy N, Nassar F, Nasser G, Grosovski M. Olive oil consumption and non-alcoholic fatty liver disease. World J Gastroenterol. 2009;15(15):1809-15.
Tsuruta Y, Nagao K, Kai S, Tsuge K, Yoshimura T, Koganemaru K et al. Polyphenolic extract of lotus root (edible rhizome of Nelumbo nucifera) alleviates hepatic steatosis in obese diabetic db/db mice. Lipids Health Dis. 2011;10(1):1.
Zelber-Sagi S, Ratziu V, Oren R. Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol. 2011;17(29):3377-89.
Li L, Zhang X-j, Lan Y, Xu L, Zhang X-z, Wang H-h. Treatment of non-alcoholic fatty liver disease by Qianggan Capsule (强肝胶囊). Chin J Integr Med. 2010;16:23-7.
Luper S. A review of plants used in the treatment of liver disease: part 1. Altern Med Rev. 1998;3(6):410-21.
Hashempur MH, Lari ZN, Ghoreishi PS, Daneshfard B, Ghasemi MS, Homayouni K, et al. A pilot randomized double-blind placebo-controlled trial on topical chamomile (Matricaria chamomilla L.) oil for severe carpal tunnel syndrome. Complement Ther Clin Pract. 2015;21(4):223-8.
Pasalar M, Lankarani KB. Herbal medicines, a prominent component in complementary and alternative medicine use in gastrointestinal field. Am J Gastroenterol. 2015;110(6):935-.
Shi K-Q, Fan Y-C, Liu W-Y, Li L-F, Chen Y-P, Zheng M-H. Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis. Mol Biol Rep. 2012;39(10):9715-22.
Toosi MN, Ardekani MRS, Minaie MB, Nazim I, Esfahani MM, Khadem E. Fatty liver disease from the perspective of traditional Iranian medicine. Quran and Medicine. 2012;1(4):117-8.
M Zarshenas M, Ranjbar Farrokhi R, Akhavein M, Reza Kiafar M. A panoramic view of chronic liver diseases and natural remedies reported in Traditional Persian Medicine. Curr Pharm Des. 2016;22(3):350-64.
Hasani-Ranjbar S, Jouyandeh Z, Abdollahi M. A systematic review of anti-obesity medicinal plants-an update. J Diabetes metab disord. 2013;12(1):1.
Xiao J, So KF, Liong EC, Tipoe GL. Recent advances in the herbal treatment of non-alcoholic Fatty liver disease. J Tradit Complement Med. 2013;3(2):88-94.
Liu ZL, Xie LZ, Zhu J, Li GQ, Grant SJ, Liu JP. Herbal medicines for fatty liver diseases. Cochrane Database Syst Rev. 2013;8.
Ebrahimi-Mameghani M, Aliashrafi S, Javadzadeh Y, AsghariJafarabadi M. The Effect of Chlorella vulgaris Supplementation on Liver En-zymes, Serum Glucose and Lipid Profile in Patients with Non-Alcoholic Fatty Liver Disease. Health Promot Perspect. 2014;4(1):107-15.
Panahi Y, Ghamarchehreh ME, Beiraghdar F, Zare R, Jalalian HR, Sahebkar A. Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial. Hepatogastroenterology. 2012;59(119):2099-103.
Sakata R, Nakamura T, Torimura T, Ueno T, Sata M. Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study. Int J Mol Med. 2013;32(5):989-94.
Hajiaghamohammadi AA, Ziaee A, Samimi R. The efficacy of licorice root extract in decreasing transaminase activities in non-alcoholic fatty liver disease: a randomized controlled clinical trial. Phytother Res. 2012;26(9):1381-4.
Wong VW, Wong GL, Chan AW, Chu WC, Choi PC, Chim AM, et al. Treatment of non-alcoholic steatohepatitis with Phyllanthus urinaria: a randomized trial. J Gastroenterol Hepatol. 2013;28(1):57-62.
Hashemi SJ, Hajiani E, Sardabi EH. A placebo-controlled trial of silymarin in patients with nonalcoholic fatty liver disease. Hepat Mon. 2009;9(4):265-70.
Shavakhi A, Torki M, Khodadoostan M, Shavakhi S. Effects of cumin on nonalcoholic steatohepatitis: A double blind, randomised, controlled trial. Adv Biomed Res. 2015;4.
Kashkooli RI, Najafi SS, Sharif F, Hamedi A, Asl MKH, Kalyani MN, et al. The Effect of Berberis Vulgaris Extract on Transaminase Activities in Non-Alcoholic Fatty Liver Disease. Hepat Mon. 2015;15(2).
Askari F, Rashidkhani B, Hekmatdoost A. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients. Nutr Res. 2014;34(2):143-8.
Caporaso N, Morisco F, Camera S, Graziani G, Donnarumma L, Ritieni A. Dietary approach in the prevention and treatment of NAFLD. Front Biosci (Landmark Ed). 2011;17:2259-68.
Centis E, Marzocchi R, Suppini A, Dalle Grave R, Villanova N, J Hickman I et al. The role of lifestyle change in the prevention and treatment of NAFLD. Curr Pharm Des. 2013;19(29):5270-9.
Hossain N, Kanwar P, Mohanty SR. A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD. Gastroenterol Res Prac. 2016;2016.
Golshani AR, Daneshfard B, Mosleh G, Salehi AR. Drugs and Pharmacology in the Islamic Middle Era. Pharm Hist (Lond). 2015;45(3):64-9.
Sakata R, Ueno T, Nakamura T, Hashimoto O, Sakamoto M, Torimura T, et al. 713 Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease patients: Double-blind placebo-controlled study. J Hepatol. 2006;44:S262.
Mosaffa-Jahromi M, Pasalar M, Afsharypuor S, Choopani R, Mosaddegh M, Kamalinejad M, et al. Preventive Care for Gastrointestinal Disorders; Role of Herbal Medicines in Traditional Persian Medicine. Jundishapur J Nat Pharm Prod. 2015;10(4):e21029.
Pasalar M, Lankarani KB, Mehrabani D, Tolide-ie HR, Naseri M. The Effect of Descureania Sophia L. and Prunus Domestica L. in Prevention of Constipation among Iranian Hajj Pilgrims, Saudi Arabia. Res J Pharm Biol Chem Sci. 2013;4(2):1195-204.
Ebrahimi-Mameghani M, Aliashrafi S, Javadzadeh Y, AsghariJafarabadi M. The Effect of Chlorella vulgaris Supplementation on Liver Enzymes, Serum Glucose and Lipid Profile in Patients with Non-Alcoholic Fatty Liver Disease. Health Promot Perspec. 2014;4(1):107.
Saller R, Brignoli R, Melzer J, Meier R. An updated systematic review with meta-analysis for the clinical evidence of silymarin. Forsch Komplementrmed (2006). 2008;15(1):9-20.
Ni X, Wang H. Silymarin attenuated hepatic steatosis through regulation of lipid metabolism and oxidative stress in a mouse model of nonalcoholic fatty liver disease (NAFLD). Am J Transl Res. 2016;8(2):1073.
Espinosa C, López‐Jiménez JA, Pérez‐Llamas F, Guardiola FA, Esteban MA, Arnao MB, et al. Long‐term intake of white tea prevents oxidative damage caused by adriamycin in kidney of rats. J Sci Food Agric. 2015.
Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring). 2007;15(6):1473-83.
Wang H, Wen Y, Du Y, Yan X, Guo H, Rycroft JA, et al. Effects of catechin enriched green tea on body composition. Obesity (Silver Spring). 2010;18(4):773-9.
Refbacks
- There are currently no refbacks.